These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31587411)

  • 1. Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Hiramatsu I; Tsujimura A; Soejima M; Yoshiyama A; Nagashima Y; Ishikawa K; Uesaka Y; Nozaki T; Ogishima T; Shirai M; Mitsuhashi I; Sugimura S; Mizuno T; Noto K; Shigeta Y; Takasu J; Honda S; Iwata S; Horie S
    Int J Urol; 2020 Jan; 27(1):53-57. PubMed ID: 31587411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tadalafil Ameliorates Symptoms of Patients with Benign Prostatic Hyperplasia Complicated by Chronic Pelvic Pain Syndrome].
    Nishino Y; Miwa K; Moriyama Y; Fujihiro S; Masue T; Kikuchi M; Nakai C; Deguchi T
    Hinyokika Kiyo; 2017 Mar; 63(3):101-105. PubMed ID: 28331166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
    Yokoyama O; Ozeki A; Suzuki N; Murakami M
    Int J Urol; 2018 Mar; 25(3):240-245. PubMed ID: 29094398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo.
    Roehrborn CG; Casabé A; Glina S; Sorsaburu S; Henneges C; Viktrup L
    Int J Urol; 2015 Jun; 22(6):582-7. PubMed ID: 25827166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental rodent models of chronic prostatitis: effect of phosphodiesterase 5 inhibitor on chronic pelvic-pain-related behavior].
    Yamaguchi H; Kurita M; Yoshinaga R; Asao Y; Oka M
    Nihon Yakurigaku Zasshi; 2019; 154(5):259-264. PubMed ID: 31735755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tadalafil on male lower urinary tract symptoms: an integrated analysis of storage and voiding international prostate symptom subscores from four randomised controlled trials.
    Chapple CR; Roehrborn CG; McVary K; Ilo D; Henneges C; Viktrup L
    Eur Urol; 2015 Jan; 67(1):114-122. PubMed ID: 25301757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study.
    Takeda M; Yokoyama O; Yoshida M; Nishizawa O; Hirata K; Nakaoka R; Takita Y; Murakami M
    Int J Urol; 2017 Jul; 24(7):539-547. PubMed ID: 28556284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms due to benign prostatic hyperplasia: A double-blinded, randomized, pilot clinical trial.
    Lee CL; Shin HK; Lee JY; Kwon O; Seo CS; Kim AR; Seo BN; Yang SW; Song KH; Lim JS; Park JM; Na YG; Shin JH
    Int J Urol; 2022 Jun; 29(6):503-509. PubMed ID: 35297106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea.
    Takeda M; Yokoyama O; Lee SW; Murakami M; Morisaki Y; Viktrup L
    Int J Urol; 2014 Jul; 21(7):670-5. PubMed ID: 24571205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study).
    Yamanishi T; Kaga K; Sakata K; Yokoyama T; Kageyama S; Fuse M; Tokunaga S
    Neurourol Urodyn; 2020 Feb; 39(2):804-812. PubMed ID: 31961963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Roehrborn CG; Kaminetsky JC; Auerbach SM; Wachs B; Young JM; Esler A; Sides GD; Denes BS
    J Urol; 2007 Apr; 177(4):1401-7. PubMed ID: 17382741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
    McVary KT; Peterson A; Donatucci CF; Baygani S; Henneges C; Clouth J; Wong D; Oelke M
    J Urol; 2016 Sep; 196(3):824-30. PubMed ID: 27105760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?
    Egan KB; Miner MM; Suh M; McVary K; Ni X; Roehrborn CG; Wittert G; Wong DG; Rosen RC
    Andrology; 2015 Nov; 3(6):1165-72. PubMed ID: 26452447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil 5 mg Once Daily Improved Each IPSS Subscore, QOL, and Nocturia in Elderly BPH Patients over 70 Years Old in a Real-World Clinical Setting.
    Kuno T; Tamura K; Fukuhara H; Fukata S; Ashida S; Karashima T; Sawada K; Yasuda M; Watanabe H; Komatsu F; Kuroiwa H; Saito M; Inoue K
    Urol Int; 2022; 106(10):1005-1011. PubMed ID: 34673648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
    Tanaka T
    Int J Urol; 2020 Jan; 27(1):58-59. PubMed ID: 31602710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.